
Profile
Contact Information
Contact: Darlene Harbour
Phone: 800-214-8714 <br />505-348-9500
Fax: 505-348-8546
Email: Click here to see email.
Website: http://www.lsrtrials.com
Center Information
Darlene Harbour
President
Lovelace Scientific Resources - Albuquerque
2441 Ridgecrest Drive SE
Albuquerque, NM 87108-5129
800-214-8714
505-348-9500
505-348-8546
dharbour@lrri.org
www.lsrtrials.com
Overview
Lovelace Scientific Resources is a multidisciplinary clinical trials company specializing in phase 1 to 4 outpatient capabilities. Lovelace Scientific Resources is a network of clinical trial sites; either stand-alone research facilities or facilities incorporated into physician practices. Through clinical trials, Lovelace Scientific Resources strives to promote patient health through clinical research. By way of clinical research, patients may expand their treatment options allowing them to better manage their disease. Lovelace’s unique configuration includes sites that function independently. Benefits to the sponsors based on this site design are:
- Centralized contracting;
- Regulatory processing at each site;
- Recruiters who are high-level and mid-level medically trained RNs;
- Customized database for patient tracking;
- In-house quality assurance;
- Well-established standard operating procedures; and
- Highly experienced, certified site directors and coordinators.
This configuration is formulated to streamline communication with one individual for most business affairs. In-house quality assurance, continuous staff training and well-established standard operating procedures enhance the efficient workflow at all sites resulting in Lovelace Scientific Resources’ hallmark pledge to its customers to effectively implement and execute clinical studies with no compromise of patient safety, integrity of science or quality of data.
Our vision at Lovelace Scientific Resources is to be a nationally recognized leader for the management of clinical research studies that advance medical knowledge and improve human health.
Research Experience
Lovelace Scientific Resources was incorporated in 1987 at the Albuquerque location. The parent company, Lovelace Biomedical Research Institute (LRBRI), one of the nation’s largest independent, nonprofit biomedical research organizations, developed Lovelace Scientific Resources, providing a bridge between the basic sciences and clinical research. Since its inception, Lovelace Scientific Resources has successfully completed more than 2,000 clinical trials in diverse therapeutic categories including:
- Allergy/Immunology
- Allergic rhinitis
- Common cold
- Herpes simplex
- Vaccine
- Cardiovascular
- Atrial fibrillation
- Cardiac arrhythmia
- Congestive heart failure
- Coronary artery disease
- Dyslipidemia
- Hypertension
- Myocardial infarction
- Peripheral artery disease
- Dermatology
- Acne
- Dry skin
- Herpes zoster
- Rosacea
- Dermatitis (all types)
- Eczema
- Endocrinology/Metabolic
- Anemia
- Diabetes types 1 and 2
- Weight loss
- Diabetic peripheral neuropathy
- Metabolic syndrome
- Obesity
- Osteoporosis
- Thyroid disease
- Pre-Diabetes
- Gastrointestinal
- Constipation
- Crohn’s disease
- Duodenal ulcer
- Dyspepsia
- Erosive esophagitis
- Elevated liver enzymes
- Gastric ulcer
- NASH/cirrhosis of the liver
- Gastroesophageal reflux
- Gastroparesis
- Irritable bowel syndrome
- Ulcerative colitis
- Genitourinary
- Benign prostatic hyperplasia
- Erectile dysfunction
- Overactive bladder
- Urinary tract infection
- Infectious Disease
- Candidiasis
- Genital herpes
- Hepatitis
- Herpes labialis
- Herpes zoster
- HIV
- Influenza
- Rhinovirus
- Sexually transmitted disease
- Musculoskeletal
- Fibromyalgia
- Muscle soreness
- Muscle spasm
- Osteoarthritis
- Rheumatoid arthritis
- Pain
- Chronic pain
- Musculoskeletal pain
- Pain trials requiring schedule II investigational products
- Neuropathic pain
- Migraine
- Psychiatry
- ADHD
- Anxiety
- Bipolar
- Depression
- Generalized anxiety disorder
- Insomnia
- Women’s Health
- Dysmenorrhea
- Endometriosis
- Fibrocystic breast disease
- Hormone replacement therapy
- Hot flashes
- Osteopenia
- Overactive bladder
- Stress urinary incontinence
- Uterine fibroids
- Ophthalmology
- Macular degeneration
- Geographic Atrophy
- Diabetic Retinopathy
- Neurotrophic keratitis
- Corneal Dystrophy
- Lens Devices
- Glaucoma
Facility Description
Clinical Operations: Lovelace Scientific Resources locations:
- Albuquerque, N.M.
Technology
Lovelace Scientific Resources developed custom software to control the information flow. The system consists of:
- Patient-tracking status from initial contact to trial completion;
- Monitoring patient recruitment methods;
- Identifying patient disease states for all enrolling trials;
- Providing data to determine feasibility for future trials; and
- Overall study management.
Sites are equipped with a dedicated monitoring space with internet access and access to fax and copy machines. The site has the necessary equipment to effectively conduct clinical trial- required procedures.
Investigator Experience
The foundation of successful clinical trials starts with highly skilled and experienced principal investigators and study team members. Our team is trained in, and dedicated to following good clinical practices, the Code of Federal Regulations, as it relates to clinical research. International Council on Harmonization guidelines. Lovelace Scientific Resources’ infrastructure is designed to quickly initiate awarded clinical trials. This facilitation is a direct result of principal investigators, site directors, certified clinical research coordinators, skilled technicians, dedicated regulatory staff and resourceful patient recruiters, all of whom are exclusively committed to achieving clinical trial objectives with scrupulous attention to sponsor protocol.
The site is supported by well-established, experienced, community-based private practice investigators board-certified in their field of expertise.
Staff Expertise
Lovelace Scientific Resources site director have extensive training and experience in conducting clinical trials and are dedicated to supporting the on-going clinical trials process.